AU2517199A - Method for producing a medicament which quickly dissolves in the mouth and whichcontains acarbose as an active agent - Google Patents

Method for producing a medicament which quickly dissolves in the mouth and whichcontains acarbose as an active agent

Info

Publication number
AU2517199A
AU2517199A AU25171/99A AU2517199A AU2517199A AU 2517199 A AU2517199 A AU 2517199A AU 25171/99 A AU25171/99 A AU 25171/99A AU 2517199 A AU2517199 A AU 2517199A AU 2517199 A AU2517199 A AU 2517199A
Authority
AU
Australia
Prior art keywords
whichcontains
acarbose
medicament
mouth
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU25171/99A
Other languages
English (en)
Inventor
Johanna Berberich
Carola Portner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU2517199A publication Critical patent/AU2517199A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
AU25171/99A 1998-01-24 1999-01-12 Method for producing a medicament which quickly dissolves in the mouth and whichcontains acarbose as an active agent Abandoned AU2517199A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE1998102700 DE19802700A1 (de) 1998-01-24 1998-01-24 Verfahren zur Herstellung einer im Mund schnell zerfallenden Arzneiform, die als Wirkstoff Acarbose enthält
DE19802700 1998-01-24
PCT/EP1999/000131 WO1999037308A1 (fr) 1998-01-24 1999-01-12 Procede pour la preparation d'une forme medicamenteuse se dissolvant rapidement dans la bouche et contenant de l'acarbose comme principe actif

Publications (1)

Publication Number Publication Date
AU2517199A true AU2517199A (en) 1999-08-09

Family

ID=7855589

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25171/99A Abandoned AU2517199A (en) 1998-01-24 1999-01-12 Method for producing a medicament which quickly dissolves in the mouth and whichcontains acarbose as an active agent

Country Status (3)

Country Link
AU (1) AU2517199A (fr)
DE (1) DE19802700A1 (fr)
WO (1) WO1999037308A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2367900A (en) * 1998-12-18 2000-07-03 Bayer Corporation Chewable drug delivery system
DE10207394B4 (de) * 2002-02-21 2007-03-29 Lts Lohmann Therapie-Systeme Ag Geschmacksmaskierte oblatenförmige Arzneizubereitung
RU2010128019A (ru) * 2007-12-08 2012-01-20 Байер Шеринг Фарма Акциенгезельшафт (DE) Пероральная диспергируемая таблетка
WO2010071232A1 (fr) * 2008-12-17 2010-06-24 Sato Pharmaceutical Co., Ltd. Comprimé se désintégrant
SG184851A1 (en) * 2010-04-27 2012-11-29 Bayer Ip Gmbh Orally disintegrating tablet containing acarbose
TR201100150A2 (tr) * 2011-01-06 2012-07-23 Bi̇lgi̇ç Mahmut Suda çözünür dozaj formları
WO2013115745A1 (fr) * 2012-01-31 2013-08-08 Mahmut Bilgic Procédé de préparation de compositions pharmaceutiques (effervescentes) contenant un inhibiteur de l'apha-glucosidase (p. ex. voglibose) et de la metformine
CN104013590A (zh) * 2014-05-09 2014-09-03 万特制药(海南)有限公司 一种含阿卡波糖的药物组合物及其制备方法
EP3233066B1 (fr) 2014-12-17 2021-11-10 Empros Pharma AB Composition à libération modifiée d'orlistat et d'acarbose pour le traitement de l'obésité
EP3523252A4 (fr) * 2016-10-05 2020-07-01 Boai NKY Medical Holdings Ltd. Compositions de comprimés contenant de la polyvinylpyrrolidone réticulée et leur utilisation dans des applications de boisson

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3543999A1 (de) * 1985-12-13 1987-06-19 Bayer Ag Hochreine acarbose
TW381025B (en) * 1993-08-05 2000-02-01 Hoffmann La Roche Pharmaceutical composition containing a glucosidase inhibitor and a lipase inhibitor

Also Published As

Publication number Publication date
DE19802700A1 (de) 1999-07-29
WO1999037308A1 (fr) 1999-07-29

Similar Documents

Publication Publication Date Title
HUP0100848A3 (en) Aerosolized active agent delivery
AU5732699A (en) Corneal onlay
AU1513400A (en) A foaming tablet for cleaning the oral cavity and preparation method thereof
HUP0204170A3 (en) 5-thia-omega-substituted phenyl-prostaglandin e derivatives, process for producing the same and drugs containing the same as the active ingredient
AU3162001A (en) Medicament, a method for its production and the use thereof
AU2001267831A1 (en) DDS compound and process for the preparation thereof
AU2517199A (en) Method for producing a medicament which quickly dissolves in the mouth and whichcontains acarbose as an active agent
HU9801025D0 (en) Process for producing pharmaceutical active agent
AU2001263835A1 (en) Haemostatically active preparation containing vWF and method for the production thereof
AU6442900A (en) Aminocarbonyl-substituted benzimidazole derivatives, method for producing same and the use thereof as medicaments
AU5965399A (en) Pharmaceutically active composition
AU1554301A (en) Radioprotecting agent
HUP0203310A3 (en) Stable pharmaceutical compositions comprising benzimidazol and method for the production thereof
AU5320998A (en) Microparticles containing active substances, agents containing the same, their use in ultrasound-controlled releasing of active substances as well as the method for their production
HUP0203443A3 (en) Novel contraceptive medicament and method for producing the same
AU687948B2 (en) Antiallergy agent and process for the production thereof
AU7268800A (en) Active agent preparation for veterinary use and method for the production thereof
HUP0004386A3 (en) Methylenebisphosphonic acid derivatives, process for producing them and medicaments containing the same as active agent
AU5696400A (en) Improved software interface agent
EP1221863A4 (fr) Chewing gum contenant des agents actifs medicamenteux
AU5477100A (en) Caspase-8 crystals, models and methods
AU8888198A (en) Human thrombopoietin produced by established human cell lines, process for producing the same, and medicinal compositions containing the same
HUP0103623A3 (en) Bispiperidines as antithrombotic agents, their process for preparation and medicament containing them as active ingredient
AU2001241067A1 (en) Omega-substituted phenyl-prostaglandin e-alcohols, process for producing the same and drugs containing the same as the active ingredient
AU6473699A (en) Aqueous drug formulation for oral application

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase